Zobrazeno 1 - 10
of 1 801
pro vyhledávání: ''
Publikováno v:
Future Oncology
Introduction: Since breast imaging requires very close contact with patients, a protocol is needed to perform safe daily screening activities during the COVID-19 pandemic. Materials and methods: Patients were triaged and separated into three differen
Autor:
Elizabeth Pan, Tyler J. Nelson, Juan Javier-Desloges, Rana R. McKay, Jesse Nodora, Sandip Pravin Patel, J Kellogg Parsons, Maria Elena Martinez, James D. Murphy, Ithaar Derweesh, Christopher J. Kane, A. Karim Kader, Brent S. Rose
Publikováno v:
Cancer. 128:770-777
BACKGROUND This study was done to determine the representation of minorities, women, and the elderly in National Cancer Institute (NCI) clinical trials. METHODS This is an analysis in the NCI Clinical Data Update System. Patients were evaluated in br
Autor:
A Arencibia-Domínguez, Catalina Falo, Miguel Gil-Gil, N Manent-Molina, S Salinas-Huertas, G Campos, S Vázquez-Gallego, Hector Perez-Montero, Amparo Garcia-Tejedor, M Ortí-Asencio, M Campos-Delgado, F Tormo-Collado, A Guma, A Mestre-Jane, M Beranuy-Rodriguez, M.L. Catasús-Clavé, A Benítez-Segura, Sonia Pernas, A Luzardo-González, J Terra, M Gomila-Sancho, E Martinez-Perez, R Planas-Balagué, María Jesús Pla, J Ponce-Sebastià, B Gonzalez-Pineda, Y Valverde-Alcántara, Ana Belén Trelles Rodríguez, María E. Fernández-Montolí, M Jaraba-Armas, I Campos-Varela
Publikováno v:
Breast Disease. 41:97-108
INTRODUCTION: The Objective was to investigate the incidence of lymphedema after breast cancer treatment and to analyze the risk factors involved in a tertiary level hospital. METHODS: Prospective longitudinal observational study over 3 years post-br
Publikováno v:
JCO Precis Oncol
PURPOSE National Comprehensive Cancer Network guidelines for germline genetic testing have included pancreatic cancer in the context of additional family cancer history for many years but this was not recommended for patients with pancreatic ductal a
Autor:
Nancy Chan, Jiuping Ji, Antoinette R. Tan, Janice M. Mehnert, Alice P. Chen, Jan H. Beumer, Mansi Shah, Joseph Aisner, Murugesan Gounder, Jyoti Malhotra, Rebecca A. Moss, Yong Lin, Brian F. Kiesel, Hongxia Lin, Mark N. Stein, Michael P. Kane
Publikováno v:
Cancer Chemother Pharmacol
Purpose Veliparib (V), an oral poly(ADP-ribose) polymerase (PARP) inhibitor, potentiates effects of alkylating agents and topoisomerase inhibitors in preclinical tumor models. We conducted a phase I trial of V with iv cyclophosphamide (C) and V plus
Publikováno v:
Cancer. 128:59-64
Background Most breast cancers (BCs) in men are hormone receptor-positive. Adjuvant tamoxifen is part of the standard treatment of these patients. Small, single-institution studies have suggested that men have high rates of discontinuing adjuvant end
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background Previous research found that the cancer history of an individual’s sibling may be a better indicator than that of the parents. We aim to provide recommendations for opportunistic screening for individuals whose sibling had been diagnosed
Autor:
Arjun Sahgal, Umberto Ricardi, Hanbo Chen, Matthew Foote, Tithi Biswas, Kristin J. Redmond, Roi Dagan, Xuguang Chen, Darby Erler, Alexander V. Louie, Serena Badellino, Ian Poon
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6189-6198 (2021)
Cancer Medicine
Cancer Medicine
Background Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain. Methods An international database of patients with OMD treated wi
Autor:
Michael C. Kolios, Kashuf Fatima, Daniel DiCenzo, Greg J. Stanisz, Nicole J. Look Hong, Lakshmanan Sannachi, Divya Bhardwaj, Andrea Eisen, William T. Tran, Karina Quiaoit, Robert Dinniwell, Belinda Curpen, Frances C. Wright, Sonal Gandhi, Maureen E. Trudeau, Christine B. Brezden, Mehrdad J. Gangeh, Archya Dasgupta, Wei Yang, Gregory J. Czarnota, Arjun Sahgal, Ali Sadeghi-Naini
Publikováno v:
Cancer Medicine, Vol 9, Iss 16, Pp 5798-5806 (2020)
Cancer Medicine
Cancer Medicine
Background This study was conducted in order to develop a model for predicting response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) using pretreatment quantitative ultrasound (QUS) radiomics. Methods This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2018776d702f0a355eb56e7355a5e007
https://doi.org/10.32920/21290982
https://doi.org/10.32920/21290982
Autor:
Gary A. Palmer, Caroline G. Epstein, Michael D. Axelson, Michael E. Salazar, Matthew Kase, Martin C. Stumpe, Calvin McCarter, Ashraf T. Hafez, Joyce O'Shaughnessy, Alexandria M. Bobe, Benjamin D. Leibowitz, Ameen A. Salahudeen, Joshua S.K. Bell, Nike Beaubier, Catherine Igartua, Robert Huether, Mark D. Pegram, Louis E. Fernandes, Ruth A. Pe Benito, Sarah Sammons
Publikováno v:
Clinical Breast Cancer. 21:e340-e361
Objective/Background We performed a retrospective analysis of longitudinal real-world data (RWD) from patients with breast cancer to replicate results from clinical studies and demonstrate the feasibility of generating real-world evidence. We also as